This compound is primarily utilized in research settings to study the sigma-1 receptor, a protein implicated in various neurological and psychiatric conditions. It acts as a selective antagonist, helping scientists understand the receptor's role in diseases such as depression, anxiety, and neuropathic pain. Additionally, it is used in preclinical studies to explore potential therapeutic targets for addiction, particularly in relation to cocaine and methamphetamine abuse. Its application extends to investigating cellular mechanisms involved in neurodegeneration and neuroprotection, providing insights into conditions like Alzheimer's and Parkinson's diseases.